The Venture Codex Logo

The Venture Codex

Efung Capital

505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen, Guangdong, China

Overview

Venture capital firm investing in biomedical and health industries.

Founded

1996

Deals ยท 12mo

2

Links

WebsiteLinkedIn

Stage focus

Series A
Series B
Series C

Geographic focus

China
United States

Sector focus

Finance
Financial Services
Venture Capital

Investment portfolio

17rounds
NAMEDATESIZE
Yuewei Medical
Jan 2026Led
$14 MSeries B
Rigen Biotech
Nov 2025Led
$14 MSeries B
QureBio
Jun 2025Led
$14 MSeries C
CATUG Biotechnology
Jun 2024Led
$14 MOther Equity
Lingyi Biology
May 2023Led
$14 MSeries A
IASO Biotherapeutics
Jan 2023Participated
$74 MSeries C
Circular Code Biology
Jun 2022Participated
$20 MSeries A
Atom Bioscience & Pharmaceutical
Jan 2022Participated
$45 MSeries C
Genuine Biotech
Aug 2021Led
$100 MSeries B
HighlightLL Pharma
Jul 2021Led
$28 MSeries B
Harbour Biomed
Mar 2020Participated
$75 MSeries B
Elicio Therapeutics
Oct 2019Participated
$33 MSeries B
Yuewei Medical
Jan 2026Led
$14 MSeries B
Rigen Biotech
Nov 2025Led
$14 MSeries B
QureBio
Jun 2025Led
$14 MSeries C
CATUG Biotechnology
Jun 2024Led
$14 MOther Equity
Lingyi Biology
May 2023Led
$14 MSeries A
IASO Biotherapeutics
Jan 2023Participated
$74 MSeries C
Circular Code Biology
Jun 2022Participated
$20 MSeries A
Atom Bioscience & Pharmaceutical
Jan 2022Participated
$45 MSeries C
Genuine Biotech
Aug 2021Led
$100 MSeries B
HighlightLL Pharma
Jul 2021Led
$28 MSeries B
Harbour Biomed
Mar 2020Participated
$75 MSeries B
Elicio Therapeutics
Oct 2019Participated
$33 MSeries B
17
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Efung Capital: 17 funding rounds are recorded in the selected participation categories.All available history.
Efung Capital: 17 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A14
Series B43
Series C+13
Other Equity10

Monthly Deal Activity

Efung Capital: 17 deals are recorded across 135 months.All available history.
Efung Capital: 17 deals are recorded across 135 months. All available history
MonthDeals
Aug '151
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '171
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '182
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '181
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '191
Nov '190
Dec '190
Jan '200
Feb '200
Mar '201
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '211
Aug '211
Sep '210
Oct '210
Nov '210
Dec '210
Jan '221
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Efung Capital: Health & Life Sciences is the largest displayed sector by deal count (17 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Efung Capital: Health & Life Sciences is the largest displayed sector by deal count (17 deals). All available history
SectorDeals
Health & Life Sciences17
Manufacturing1

Deal Size Distribution

Efung Capital: 17 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Efung Capital: 17 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M7
$25M-$50M4
$50M-$100M5
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Efung Capital: China has the largest recorded deal count among the displayed regions (13 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Efung Capital: China has the largest recorded deal count among the displayed regions (13 deals). All available history
RegionDeals
China13
United States4
Efung Capital: 20 co-investors are shown, with Kaitai Capital sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Efung Capital: 20 co-investors are shown, with Kaitai Capital sharing 3 recorded deals. All available history
Co-investorShared deals
Kaitai Capital3
Hongshan Capital Group (Sequoia Capital China)2
Livzon Pharmaceutical Group2
Oriza Ventures2
YuanMing Capital2
6 Dimensions Capital1
AdvanTech1
Advantech Capital1
ArrowMark Partners1
Bay City Capital1
BioVentures Investors1
Bohai Chuangfu1
Cash Capital1
Clal Biotechnology Industries1
Clough Capital Partners1
Elite Capital1
Future Industry Ventures1
GF Xinde Life Science Investment Fund1
GIC1
Grains Valley Venture Capital1

Investment Strategy

Efung Capital: Led accounts for 41% and participating for 59% of round participation.All available history.
Efung Capital: Led accounts for 41% and participating for 59% of round participation. All available history
CategoryDeals (count)Share (%)
Led741%
Participating1059%
Efung Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Efung Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead7100%
Co-led00%

Team

Fan Rongkui
Jinqiao Zhu

Founder

Luo Fayong

Managing Director

Pai Zhu

Managing Partner

Yu Wang

Chief Scientist